Unknown

Dataset Information

0

Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.

ABSTRACT:

SUBMITTER: Arvind A 

PROVIDER: S-EPMC7725909 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.
| S-EPMC4491606 | biostudies-literature
Unknown Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis.
| S-EPMC6589210 | biostudies-literature
Unknown Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.
| S-EPMC7004886 | biostudies-literature
Unknown Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
| S-EPMC3378283 | biostudies-literature
Unknown Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
| S-EPMC4816035 | biostudies-literature
Unknown Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
| S-EPMC4208976 | biostudies-literature
Unknown Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
| S-EPMC6822168 | biostudies-literature
Unknown Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
| S-EPMC4942367 | biostudies-literature
Unknown Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
| S-EPMC6508084 | biostudies-literature
Unknown Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
| S-EPMC6756995 | biostudies-literature